Market Overview

UPDATE: Stifel Nicolaus Initiates Henry Schein at Hold on Valuation

Related HSIC
14 Healthcare Stocks Fundstrat Is Buying
Earnings Scheduled For July 29, 2015
Valuing Henry Schein For The Long Term (Seeking Alpha)

Stifel Nicolaus initiated coverage on Henry Schein (NASDAQ: HSIC) with a Hold rating.

Stifel Nicolaus commented, "Henry Schein's market share gains in N.A. dental and veterinary have outpaced that of Patterson, the company's biggest competitor. As a result, we believe Schein's premium valuation is well deserved. That said, for the stock to post 20% upside from current levels, Henry Schein would need to recapture a 20x NTM EPS multiple. The stock's peak multiple over the past three years is in the high teens."

Henry Schein closed at $82.23 on Wednesday.

Latest Ratings for HSIC

Jul 2015Evercore PartnersDowngradesBuyHold
Jun 2015RBC CapitalInitiates Coverage onOutperform
Nov 2014Credit SuisseMaintainsNeutral

View More Analyst Ratings for HSIC
View the Latest Analyst Ratings

Posted-In: Stifel NicolausAnalyst Color Initiation Intraday Update Analyst Ratings


Related Articles (HSIC)

View Comments and Join the Discussion!

Get Benzinga's Newsletters